KalVista Pharmaceuticals Inc (KALV)
9.325
+0.36
(+4.07%)
USD |
NASDAQ |
Nov 21, 16:00
9.33
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals Shareholders Equity (Quarterly): 172.80M for July 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 172.80M |
| April 30, 2024 | 206.58M |
| January 31, 2024 | 88.58M |
| October 31, 2023 | 114.45M |
| July 31, 2023 | 139.34M |
| April 30, 2023 | 161.02M |
| January 31, 2023 | 184.44M |
| October 31, 2022 | 143.81M |
| July 31, 2022 | 164.57M |
| April 30, 2022 | 185.09M |
| January 31, 2022 | 207.94M |
| October 31, 2021 | 227.47M |
| July 31, 2021 | 244.43M |
| April 30, 2021 | 257.19M |
| January 31, 2021 | 58.56M |
| October 31, 2020 | 64.98M |
| July 31, 2020 | 74.44M |
| April 30, 2020 | 83.75M |
| January 31, 2020 | 89.75M |
| October 31, 2019 | 97.79M |
| July 31, 2019 | 101.87M |
| Date | Value |
|---|---|
| April 30, 2019 | 96.74M |
| January 31, 2019 | 104.03M |
| October 31, 2018 | 106.95M |
| July 31, 2018 | 26.25M |
| April 30, 2018 | 27.25M |
| January 31, 2018 | 28.57M |
| October 31, 2017 | 31.08M |
| July 31, 2017 | 26.73M |
| April 30, 2017 | 31.33M |
| January 31, 2017 | 34.85M |
| September 30, 2016 | 33.94M |
| June 30, 2016 | 36.04M |
| March 31, 2016 | 43.07M |
| December 31, 2015 | 49.31M |
| September 30, 2015 | 54.62M |
| June 30, 2015 | 59.32M |
| March 31, 2015 | -48.97M |
| December 31, 2014 | -44.18M |
| September 30, 2014 | -39.64M |
| December 31, 2013 | -33.71M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
58.56M
Minimum
Jan 2021
257.19M
Maximum
Apr 2021
151.01M
Average
161.02M
Median
Apr 2023
Shareholders Equity (Quarterly) Benchmarks
| Nuwellis Inc | 3.179M |
| Perspective Therapeutics Inc | 328.47M |
| Electromed Inc | 41.49M |
| Xtant Medical Holdings Inc | 45.72M |
| Myomo Inc | 9.292M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 200.20M |
| Total Liabilities (Quarterly) | 27.40M |